NCT00126620 2015-07-23
Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
University Health Network, Toronto
Phase 1 Completed
Clinical Trials
4 trialsUnspecified Adult Solid Tumor, Protocol Specific × Erlotinib Hydrochloride × Other solid neoplasm × Clear all
NCT00276575 2014-11-19
Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
Duke University
Phase 1 Completed
NCT00042809 2013-01-24
Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00320073 2012-05-16
Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed